Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/11/1992 | CA1306258C Certain cycloalka-[b]-pyrazolo[3,4-d]-pyridin-3-one derivatives |
08/11/1992 | CA1306255C Polycyclic quinoline, naphthyridine and pyrazinopyridine derivatives |
08/11/1992 | CA1306253C Triazole antifungal agents |
08/11/1992 | CA1306251C Psychotropic polycyclic imides |
08/11/1992 | CA1306250C 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives |
08/11/1992 | CA1306248C Androstane-17-carboxylic acid esters process for their preparation and medecine containing them |
08/11/1992 | CA1306213C Phenanthridine derivatives, process for the preparation thereof, and compositions containing them |
08/11/1992 | CA1306197C Use of 5-(substituted phenyl)-oxazolidinone derivatives for treatment of depression |
08/11/1992 | CA1306196C Pharmaceutical composition containing a benzol urea |
08/11/1992 | CA1306192C Medicament containing a silicon derivative of menthol |
08/10/1992 | WO1992013539A1 Ovulation-preventing agent for hormonal contraception |
08/10/1992 | CA2060954A1 Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs |
08/10/1992 | CA2060937A1 Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation |
08/10/1992 | CA2060856A1 Amino acid derivatives |
08/09/1992 | WO1992013869A1 Methylene phosphonate nucleoside analogs and oligonucleotide analogs made therefrom |
08/09/1992 | WO1992012715A2 The use of loperamide and related compounds for treatment of respiratory disease symptoms |
08/09/1992 | CA2103721A1 Methylene phosphonate nucleoside analogs and oligonucleotide analogs made therefrom |
08/09/1992 | CA2099245A1 Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers |
08/09/1992 | CA2060788A1 Certain benzodioxole, benzodioxane and benzodioxepin derivatives |
08/09/1992 | CA2060493A1 Sustained-release pranoprofen preparation |
08/08/1992 | WO1992013848A1 Lipoxygenase-inhibiting hydroxamic acid and n-hydroxyurea derivatives |
08/08/1992 | WO1992013831A1 Hydroxamic acid derivatives, process for their preparation and use thereof |
08/08/1992 | WO1992013524A1 Pharmaceutical for treating viral diseases |
08/08/1992 | WO1992013523A1 Pharmaceutical product for treating viral diseases |
08/08/1992 | CA2101539A1 Lipoxygenase-inhibiting hydroxamic acid and n-hydroxyurea derivatives |
08/08/1992 | CA2100661A1 Hydroxamic acid derivatives, process for their preparation and use thereof |
08/08/1992 | CA2079868A1 Pharmaceutical for treating viral diseases |
08/08/1992 | CA2079867A1 Pharmaceutical product for treating viral diseases |
08/08/1992 | CA2060843A1 N-substituted derivatives of quinoleine, process for their preparation, new intermediates obtaines, their application as drugs and pharmaceutical compositions containing them |
08/08/1992 | CA2060771A1 Nitrogenated bicyclic derivatives substitutes by a benzyl radical, process for their preparation, novel intermediates thus obtaines, their applications as drugs, and pharmaceutical compositions containing them |
08/08/1992 | CA2060750A1 Bicyclic nitrogenated derivatives, process for their preparation, novel intermediates thus obtaines, their applications as drugs, and phamarceutical compositions containing them |
08/08/1992 | CA2060687A1 Pyridobenzodiazepines dipyrido¬3,2-b:2',3'-e|¬1,4| diazepines and their use in the prevention or treatment of hiv infection |
08/08/1992 | CA2038789A1 Antiperspirant formulations |
08/07/1992 | WO1992013798A1 Peroxyacid bleach precursor compositions |
08/07/1992 | CA2101448A1 Preoxyacid bleach precursor compositions |
08/06/1992 | WO1992013095A1 Methods for treating tumor necrosis factor mediated diseases |
08/06/1992 | WO1992013086A1 Arachidonic acid and methods for the production and use thereof |
08/06/1992 | WO1992012991A1 Triterpene derivative |
08/06/1992 | WO1992012990A1 14,16β-ETHANO-15β,161 -CYCLO-14β-ESTRA-1,3,5(10)-TRIENES |
08/06/1992 | WO1992012989A1 New sterol esters and sterol phosphorus compounds |
08/06/1992 | WO1992012988A1 Novel macrolide compound and production thereof |
08/06/1992 | WO1992012986A1 Sphingoglycolipid |
08/06/1992 | WO1992012980A1 OPTICALLY ACTIVE 5H-PYRROLO[3,4-b]PYRAZINE DERIVATIVE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
08/06/1992 | WO1992012963A1 23-oxa derivatives of d-series vitamins, method of preparing them, pharmaceutical preparations containing them, and the use of such preparations as drugs |
08/06/1992 | WO1992012961A1 Benzamides |
08/06/1992 | WO1992012960A2 Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions for enteral and parenteral nutrition |
08/06/1992 | WO1992012952A1 Malic acid derivatives and compositions for the treatment of psoriasis |
08/06/1992 | WO1992012730A1 A method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion, and the use of said agents for said purpose |
08/06/1992 | WO1992012717A2 A composition containing a tetracycline and use for inhibiting angiogenesis |
08/06/1992 | WO1992012716A1 Pharmaceutical composition containing granisetron and dexamethasone |
08/06/1992 | WO1992012714A2 Food supplement |
08/06/1992 | WO1992012713A1 Compositions |
08/06/1992 | WO1992012710A1 Orally administerable drugs for the treatment of central dopamine deficiency conditions |
08/06/1992 | WO1992012707A1 A benzoylurea-containing composition for parasite control in animals |
08/06/1992 | WO1992006954A3 Pyrrolidine dione derivatives |
08/06/1992 | WO1992001675A3 Substituted bicyclic bis-aryl compounds exhibiting selective leukotriene b4 antagonist activity, their preparation and use in pharmaceutical compositions |
08/06/1992 | WO1990015600A3 Treatment of chronic inflammatory joint disease with arylsulfonamides |
08/06/1992 | DE4103451A1 Drug containing R-sulpiride for treatment of psychoses - can be administered in lower doses than racemic compositions, also use of S-isomer for treating depression |
08/06/1992 | DE4103360A1 Use of acetyl-cysteine and isotonic sodium chloride (0.9 per cent) - for treating bronchial asthma and bronchitis-induced spasms |
08/06/1992 | DE4103177A1 Thiazolo-(2,3-a)isoindol-derivate und diese enthaltende arzneimittel Thiazolo (2,3-a) isoindole derivatives and pharmaceutical compositions containing them |
08/06/1992 | CA2100863A1 Adenosine kinase inhibitors |
08/06/1992 | CA2060622A1 2,4- and 2,5-bistetrazolylpyridines, a process for the preparation thereof and the use thereof as pharmaceuticals |
08/06/1992 | CA2060594A1 Licidal and lice-ovicidal pharmaceutical and cosmetic formulations |
08/05/1992 | EP0497740A1 Benzyloxyphenyl derivatives |
08/05/1992 | EP0497724A1 An agent for disintegrating gallstones |
08/05/1992 | EP0497695A1 N-2-chlorobenzyl-2-oxo and N-2-chlorobenzyl-2,2-dioxo-1,2,3-oxathiazolidine derivatives, their preparation and synthesis of thieno[3,2-c]pyridine derivatives therefrom |
08/05/1992 | EP0497659A1 Aryl(or Heteroaryl)-piperazinyl-alkyl-azole derivatives, their preparation and their application as drugs |
08/05/1992 | EP0497658A1 Use of (omega-(4-(2-pyrimidinyl)-1-piperazinyl)-alkyl)1H-azole derivatives for the preparation of medicines for the treatment of troubles of the capability of knowing functions |
08/05/1992 | EP0497629A1 Heterocyclic amido prostaglandin analogs |
08/05/1992 | EP0497609A1 Pyrimido-benzothiazine derivatives for the treatment of inflammation, allergy and cardiovascular disease |
08/05/1992 | EP0497564A1 Benzamides |
08/05/1992 | EP0497516A1 Substituted pyrrolo-fused 6-membered heterocycles as angiotensin II antagonists |
08/05/1992 | EP0497515A1 New process for producing FK-506 |
08/05/1992 | EP0497512A2 Imidazole, triazole and tetrazole derivatives |
08/05/1992 | EP0497415A1 3-Quinuclidine derivatives |
08/05/1992 | EP0497353A2 Oral antibacterial compositions and method for the improvement of gastrointestinal absorption of penem or carbapenem antibiotics |
08/05/1992 | EP0497341A2 Synergistic composition comprising a fibroblast growth factor and a sulfated polysaccahride, for use as antiviral agent |
08/05/1992 | EP0497331A2 Process for the preparation of tablets or film-coated tablets |
08/05/1992 | EP0497314A1 Use of azapirones in attention deficit hyperactivity disorder |
08/05/1992 | EP0497313A1 Allosamidin compounds and a process for production thereof |
08/05/1992 | EP0497303A2 Carbamic acid derivatives and method for preparing the same |
08/05/1992 | EP0497300A1 Natural products with ten-ring lactone structure, method for their preparation and their use |
08/05/1992 | EP0497299A1 Decarestrictine and related compounds, process for their preparation and use |
08/05/1992 | EP0497258A2 Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer |
08/05/1992 | EP0497240A1 Preparation for controlled release of drugs for ruminants |
08/05/1992 | EP0497234A2 Phosphatidylinositol analogues, inhibitors of phosphatidyl-inositol-specific phospholipase C |
08/05/1992 | EP0497202A1 Polyamine thiols as radioprotective agents |
08/05/1992 | EP0497201A1 Tricyclic compounds and intermediates thereof |
08/05/1992 | EP0497192A2 Amino acid derivatives |
08/05/1992 | EP0497177A1 Vitamin containing formulations and their production |
08/05/1992 | EP0497162A1 Pharmaceutical compositions containing orally absorbable glycosaminoglycans |
08/05/1992 | EP0497158A1 Pharmaceutical chewing-gum containing acetylsalicylic acid |
08/05/1992 | EP0497150A1 Angiotensin II receptor blocking 2,3,6-substituted quinazolones |
08/05/1992 | EP0497127A2 Substituted 3-aryl-pyrrolidine-2,4-diones |
08/05/1992 | EP0497125A1 New process for preparing 2'-(diethylamino)rifamycin P (P/DEA) |
08/05/1992 | EP0497122A1 Substituted 3-aminosydnonimines, process for their preparation and their use |
08/05/1992 | EP0497121A1 Tetrazole derivatives, process for their production and their application |
08/05/1992 | EP0497091A1 Bridged cyclic ketal derivatives |
08/05/1992 | EP0497085A1 Heterocyclic ketone prostaglandin analogs |
08/05/1992 | EP0496858A1 Pharmaceutical compositions with mucolytic and antitussive activity containing (-)-trans-sobrerol |